Press Release | Newsroom | Medtronic | Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2017

Press Release

Printer Friendly Version View printer-friendly version
Download PDF Download PDF
<< Back
Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2017

DUBLIN - Nov. 11, 2016 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for its second quarter of fiscal year 2017 on Tuesday, November 22, 2016. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at http://newsroom.medtronic.com. The news release will include summary financial information for the company's second quarter of fiscal year 2017, which ended on Friday, October 28, 2016.

Medtronic will host a webcast at 7:00 a.m. CST to discuss financial results for its second quarter of fiscal year 2017. The webcast can be accessed at http://investorrelations.medtronic.com on November 22, 2016.
                                                                                        
Within 24 hours of the webcast, a replay and transcript of the prepared remarks will be available by clicking on the Investor Events link at http://investorrelations.medtronic.com.

Looking ahead, Medtronic plans to report its 2017 fiscal year third and fourth quarter financial results on Tuesday, February 21, 2017, and Thursday, May 25, 2017, respectively. Additional details will be provided closer to the specific quarterly earnings release date.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 88,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-

 

Contacts:
Fernando Vivanco
Public Relations
+1-763-505-3780

Ryan Weispfenning
Investor Relations
+1-763-505-4626


X